ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure

NCT05117736 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped The trial was prematurely terminated due to safety concerns.

Conditions

Systemic Right Ventricle
Heart Failure

Interventions

DRUG: Sacubitril / Valsartan Oral Tablet
DRUG: Placebo

Sponsor

Montreal Heart Institute

Collaborators

[object Object]